Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2001
05/31/2001CA2391499A1 Compositions and methods for treatment of allergic disorders
05/31/2001CA2390767A1 Nontoxic vernix compositions and method of producing
05/31/2001CA2390462A1 Article comprising a diffuser with flow control features
05/31/2001CA2389869A1 Preparation for nasal administration
05/31/2001CA2389568A1 Osmotic dosage form comprising first and second coats
05/31/2001CA2389537A1 Mixture of pomegranate seed oil and juice products
05/31/2001CA2387575A1 Coating
05/31/2001CA2386979A1 Periodontitis treating agent
05/31/2001CA2383058A1 Aerosol airflow control system and method
05/30/2001EP1103282A1 Therapeutic aluminium patch
05/30/2001EP1103266A2 Formulations of curcumine
05/30/2001EP1103264A2 Active oxygen containing solution for promoting growth of tissue cells at wound sites
05/30/2001EP1103262A1 Antifungal solutions
05/30/2001EP1103260A2 Transdermal system for the administration of clonidine
05/30/2001EP1103258A1 Solid preparation containing sparingly soluble nsaids
05/30/2001EP1103254A1 Process to manufacture starch-containing shaped bodies,mass containing homogenized starch and device to manufacture soft capsules
05/30/2001EP1103253A2 Aqueous film coating agent and oral solid preparation
05/30/2001EP1103252A1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
05/30/2001EP1103192A1 Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition
05/30/2001EP1102788A2 Prevention and treatment of viral disease
05/30/2001EP1102775A1 Novel phospholipids with unsaturated alkyl and acyl chains
05/30/2001EP1102758A1 Particle-forming compositions containing fused pyrrolocarbazoles
05/30/2001EP1102742A2 Compounds and compositions for delivering active agents
05/30/2001EP1102722A1 Method for dispersing insoluble mineral sediments and additives for carrying out this method
05/30/2001EP1102604A1 Drug releasing elastic band and method
05/30/2001EP1102599A1 Protease inhibitors for use in the treatment of psoriasis
05/30/2001EP1102594A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity
05/30/2001EP1102584A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/30/2001EP1102581A1 A microemulsion forming composition for the sustained release of an active agent
05/30/2001EP1102580A2 Formulations having probiotically active microorganisms
05/30/2001EP1102579A1 Medicinal aerosol formulations
05/30/2001EP1017741B1 Non-expanding agent method for producing flat-shaped polymer foams
05/30/2001EP0929292B1 Method and composition for rewetting contact lenses and relieving eye dryness
05/30/2001EP0840570A4 Apparatus and method for making gas-filled vesicles of optimal size
05/30/2001EP0817610B1 Sterile ophthalmological gel preparation applicable in drops and process for producing it
05/30/2001EP0755245B1 Process and apparatus for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
05/30/2001EP0727988B1 Aids prophylactic lubricating composition and devices for its use
05/30/2001EP0689441B1 Pharmaceutical composition in form of a kit comprising prostaglandin e1
05/30/2001EP0662320B1 Dry gel composition
05/30/2001EP0621788B1 Hemoregulatory peptides
05/30/2001CN2431895Y Body-building belt
05/30/2001CN2431880Y Gynaecological medical suppository
05/30/2001CN2431879Y Cervical chitin complex pellicle
05/30/2001CN1297364A Preparation contg. calcium hydroxide, dehydric or polyvalent alcohol and fatty oil of vegetable or animal origin, and use thereof for regenerating collagen
05/30/2001CN1297359A Ophthalmic composition comprising beta-blocker
05/30/2001CN1297358A Glycolipid creams
05/30/2001CN1297349A Adhesive preparations
05/30/2001CN1297344A Method and compositions for in situ formation of protective and/or medicated film on body tissue
05/30/2001CN1296846A Zhiqi plaster and its preparing process
05/30/2001CN1296842A 'Sanjisan' for treating syphilis
05/30/2001CN1296835A Exterior applied liquid Chinese medicine for treating diarrhea
05/30/2001CN1296827A Quick-acting bone-setting powder medicine
05/30/2001CN1296821A Medicine for treating hepatism and its preparing process
05/30/2001CN1296814A Medical aerosol without freon for treating diseases in respiratory system
05/30/2001CN1066336C Pharmaceutical composition for treatment of alcohol addiction
05/29/2001USRE37198 Stable blend
05/29/2001US6239228 Pressure sensitive adhesive containing macromer having repeat hydrophilic moieties
05/29/2001US6239180 Transdermal therapeutic device and method with capsaicin and capsaicin analogs
05/29/2001US6239177 Dissolution medium of crotamiton and n-methyl-2-pyrrolidone
05/29/2001US6239172 Mixture of angiogenic growth factor and l-arginine; brain and cardiovascular disorders
05/29/2001US6239165 Liquid pharmaceutical formulation containing zotepine
05/29/2001US6239153 Insulin sensitivity enhancer with squaline synthesis inhibitor, which shows a potent depressive effect on diabetic hyperglycemia,
05/29/2001US6239141 Antibiotic
05/29/2001US6239124 Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin
05/29/2001US6239117 Dna sequence encoding protein, expression, treating erectile dysfunction, bladder dysfunction, and other smooth muscle disorders.
05/29/2001US6239116 Immunostimulatory nucleic acid molecules
05/29/2001US6239113 Topical treatment or prevention of ocular infections
05/29/2001US6239112 Water miscible macrolide solutions
05/29/2001US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol
05/29/2001US6238888 Keratinocyte growth factor-2 formulations
05/29/2001US6238705 Bioerodible porous compositions
05/29/2001US6238704 Sustained-release preparation utilizing thermal change and process for the production thereof
05/29/2001US6238703 Core with overcoatings
05/29/2001US6238702 High load formulations and methods for providing prolonged local anesthesia
05/29/2001US6238700 Method for preventing crystal formation in a dispersion of a liquid in a matrix
05/29/2001US6238699 Pharmaceutical formulations containing a combination of carbidopa and levidopa
05/29/2001US6238698 Multilayer tablet
05/29/2001US6238697 Methods and formulations for making bupropion hydrochloride tablets using direct compression
05/29/2001US6238696 Plant extracts
05/29/2001US6238695 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
05/29/2001US6238694 Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration
05/29/2001US6238693 Multilayer; backings, matrix and protective coatings
05/29/2001US6238692 Containing cyanoacrylate adhesive
05/29/2001US6238691 Hydrogel wound dressing and the method of making and using the same
05/29/2001US6238689 Intestinal absorption of nicotine to treat nicotine responsive conditions
05/29/2001US6238688 Joining using heat sensitive polymer gel, hydrophobic polymer matrix and interpenetrating polymer network
05/29/2001US6238687 Sustained release; medical equipment
05/29/2001US6238683 Drug delivery
05/29/2001US6238682 Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation
05/29/2001US6238677 Spherical shells of polysaccharide
05/29/2001US6238673 Drying grape extract
05/29/2001US6238664 Process for stabilizing proteins
05/29/2001US6238661 Use of bacterial phage associated lysing enzymes for treating various illnesses
05/29/2001US6238657 Three-dimensional silicone elastomers having polyether and higher alkyl functionality in their molecules form crosslinked networks; used as emulsifiers for oil-in-oil emulsion of silicone oils with organic oils
05/29/2001US6238650 Said sunscreen active ingredient is in the form of sol-gel microcapsules containing at least one sunscreen compound.
05/29/2001US6238647 Anticholinergic medicament which is selected from the group consisting of ipratropium, atropine, oxitropium and salts thereof
05/29/2001US6238646 Aqueous aerosol compositions for delivery of atomized oil
05/29/2001US6238645 Methods of oxygenating tissues
05/29/2001US6238362 Contour of a transdermal therapeutic system
05/29/2001US6238284 Transdermal compositions with enhanced skin penetration properties